Novo Nordisk (NVO.US) considers entering the hair loss market as its "post-Wegovy" strategy seeks new growth opportunities.

智通财经2026/09/23 00:31

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

```htmlSmart Finance APP reports that Novo Nordisk (NVO.US) is turning its attention to the hair loss market—the Ozempic producer is seeking diversification as part of its “post Wegovy” growth strategy. “We can leverage our scientific expertise to potentially enter this field,” said Martin Lange, Chief Science Officer at Novo Nordisk, adding, “This may not necessarily be the direction we pursue first, but it is definitely a clear possibility.”```

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Novo Nordisk (NVO.US) considers entering the hair loss market as its "post-Wegovy" strategy seeks new growth opportunities.

You may also like

Crypto prices